221 related articles for article (PubMed ID: 24126842)
1. Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.
Teixeira TF; Gentile LB; da Silva TC; Mennecier G; Chaible LM; Cogliati B; Roman MA; Gioso MA; Dagli ML
Vet Res Commun; 2014 Mar; 38(1):29-38. PubMed ID: 24126842
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of routine cytology and immunocytochemistry in preoperative diagnosis of oral amelanotic melanomas in dogs.
Przeździecki R; Czopowicz M; Sapierzyński R
Vet Clin Pathol; 2015 Dec; 44(4):597-604. PubMed ID: 26398102
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Global DNA Methylation in Canine Melanotic and Amelanotic Oral Mucosal Melanomas and Peripheral Blood Leukocytes From the Same Patients With OMM: First Study.
Scattone NV; Epiphanio TMF; Caddrobi KG; Ferrão JSP; Hernandez-Blazquez FJ; Loureiro APM; Massoco CO; Dagli MLZ
Front Vet Sci; 2021; 8():680181. PubMed ID: 34504885
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
Smedley RC; Lamoureux J; Sledge DG; Kiupel M
Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.
Choi C; Kusewitt DF
Vet Pathol; 2003 Nov; 40(6):713-8. PubMed ID: 14608029
[TBL] [Abstract][Full Text] [Related]
8. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
Han JI; Kim Y; Kim DY; Na KJ
Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
[TBL] [Abstract][Full Text] [Related]
9. BILATERALLY SYMMETRICAL ORAL AMELANOTIC MELANOMA IN A BOA CONSTRICTOR (BOA CONSTRICTOR CONSTRICTOR).
Thompson KA; Campbell M; Levens G; Agnew D
J Zoo Wildl Med; 2015 Sep; 46(3):629-32. PubMed ID: 26352976
[TBL] [Abstract][Full Text] [Related]
10. Comparative expression of cyclooxygenase 2 and Ki67 in amelanotic and conventional oral melanomas.
Soares CD; Hernandez-Guerrero JC; Andrade BA; Romañach MJ; Mosqueda-Taylor A; Carlos R; Macedo MR; Almeida OP; Jorge J
Med Oral Patol Oral Cir Bucal; 2020 Nov; 25(6):e728-e731. PubMed ID: 32388516
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
12. Oral Amelanotic Melanomas: Clinicopathologic Features of 8 Cases and Review of the Literature.
Soares CD; Carlos R; Andrade BAB; Cunha JLS; Agostini M; Romañach MJ; Hernandez-Guerrero JC; Mosqueda-Taylor A; Almeida OP; Jorge J
Int J Surg Pathol; 2021 May; 29(3):263-272. PubMed ID: 32734791
[TBL] [Abstract][Full Text] [Related]
13. Primary amelanotic mucosal melanoma of the oronasal region: report of two new cases and literature review.
Paulo LF; Servato JP; Rosa RR; Oliveira MT; Faria PR; Silva SJ; Cardoso SV; Loyola AM
Oral Maxillofac Surg; 2015 Dec; 19(4):333-9. PubMed ID: 25934245
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma.
Mayayo SL; Prestigio S; Maniscalco L; Rosa G; Aricò A; Maria R; Cavallo F; Ferrone S; Buracco P; Iussich S
Vet J; 2011 Nov; 190(2):e26-e30. PubMed ID: 21482159
[TBL] [Abstract][Full Text] [Related]
16. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
[TBL] [Abstract][Full Text] [Related]
17. Prognosis after surgical excision of canine melanomas.
Bostock DE
Vet Pathol; 1979 Jan; 16(1):32-40. PubMed ID: 462717
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy of oral malignant melanomas in dogs.
Blackwood L; Dobson JM
J Am Vet Med Assoc; 1996 Jul; 209(1):98-102. PubMed ID: 8926220
[TBL] [Abstract][Full Text] [Related]
19. [Developmental studies on melanoma of the skin and mouth mucosa of dogs].
Frese K
Vet Pathol; 1978 Jul; 15(4):461-73. PubMed ID: 695220
[TBL] [Abstract][Full Text] [Related]
20. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases.
Orlow SJ; Silvers WK; Zhou BK; Mintz B
Cancer Res; 1998 Apr; 58(7):1521-3. PubMed ID: 9537258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
